(Q77374966)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

5 December 2019

main subject

1 reference

1 reference

10

P Rutgeerts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

G D'haens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Van Deventer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R Van Hogezand

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Chalmers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Kothe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Baert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Braakman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Schaible

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

K Geboes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

English

0 references

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

1029-1034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestiv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

A controlled trial of azathioprine in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

A controlled double blind study of azathioprine in the management of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Controlled trial of azathioprine in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970005-3

10.1016/S0016-5085(99)70005-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10220494%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference